Morgan & Morgan, which describes itself as America’s largest personal-injury firm, announced on 14 September that it would invest at least US$1 billion in AI and technology over the next decade.
The firm says it has already spent US$300 million developing MX2, an internal platform used to extract medical information, generate case documents and support trial preparation. According to the firm, MX2 now has nearly 5,000 monthly users. It plans to offer the platform to other firms on an invitation-only basis by the end of 2027, although pricing has not been disclosed.
The announcement is notable because Morgan & Morgan is moving beyond purchasing legal technology to becoming a potential legaltech vendor. Its competitive asset is not simply access to an AI model, but the workflows, data and operational knowledge accumulated through a large litigation practice.
That transition also creates governance questions. A system developed within one firm must operate safely across firms with different client duties, documents, supervision arrangements and professional-risk tolerances. Morgan & Morgan itself had two lawyers sanctioned over AI-generated false citations in 2025; its chief transformation officer says the firm subsequently strengthened training and review processes.
For Australian practices, the broader signal is that proprietary legal workflows may increasingly become commercial products—making verification, provenance and practitioner control central to their defensibility.
Source: Reuters reporting.
Leave a Reply